These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17762442)

  • 1. Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.
    Calvin DP; Hammond ME; Pajak TF; Trotti AM; Meredith RF; Rotman M; Jones CU; Byhardt RW; Demas WF; Ang KK; Fu KK;
    Am J Clin Oncol; 2007 Aug; 30(4):406-19. PubMed ID: 17762442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy.
    Dunphy F; Stack BC; Boyd JH; Dunleavy TL; Kim HJ; Dunphy CH
    Anticancer Res; 2002; 22(3):1755-8. PubMed ID: 12168864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.
    Foote RL; Weidner N; Harris J; Hammond E; Lewis JE; Vuong T; Ang KK; Fu KK
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):745-53. PubMed ID: 15708253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters.
    Lentsch EJ; Goudy S; Sosnowski J; Major S; Bumpous JM
    Laryngoscope; 2006 Mar; 116(3):397-400. PubMed ID: 16540897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic effects of radiotherapy but not initial microvessel density predict survival in inoperable oropharyngeal squamous cell carcinoma.
    Lövey J; Lukits J; Remenár E; Koronczay K; Kásler M; Németh G; Tímár J
    Strahlenther Onkol; 2006 Mar; 182(3):149-56. PubMed ID: 16520909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
    Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
    Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
    Yodavudh S; Tangjitgamol S; Puangsa-art S
    J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck.
    Carrau RL; Barnes EL; Snyderman CH; Petruzzelli G; Kachman K; Rueger R; D'Amico F; Johnson JT
    Invasion Metastasis; 1995; 15(5-6):197-202. PubMed ID: 8765194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
    Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
    Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiation-induced alterations in microvessel density as predictor of treatment efficiency in oropharyngeal cancer].
    Lövey J; Lukits J; Remenár E; Koronczay K; Kásler M; Németh G; Tímár J
    Magy Onkol; 2005; 49(4):307-13. PubMed ID: 16518474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pissakas G; Gatter KC; Harris AL
    Anticancer Res; 2001; 21(6B):4301-9. PubMed ID: 11908684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma.
    Ranieri G; Labriola A; Achille G; Florio G; Zito AF; Grammatica L; Paradiso A
    Int J Oncol; 2002 Dec; 21(6):1317-23. PubMed ID: 12429983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.